mHealth in Clinical Trials Market Outlook: 2018-2020

Report Overview

Technology, especially smartphones, has transformed our daily lives. Over the past decade, ‘touch of a button’ access has disrupted many different industries from retail (e.g., Amazon) to transportation (e.g., Uber and Lyft). Today, technology has the potential to transform the way biopharma conducts clinical trials and perhaps, to disrupt the clinical development of medicines altogether.

For this study, Industry Standard Research (ISR) collected both qualitative and quantitative data. Qualitative telephone interviews were used to gain insight into mHealth expert viewpoints, while a quantitative, internet-based survey was used to collect hard data on familiarity with mHealth, anticipated implementation, and usage rates in recent or soon-to-be conducted clinical trials.

What you will learn:

• mHealth usage rates and adoption plans
• Whether mHealth technologies contribute to cost savings in clinical trials
• Road blocks to mHealth use in clinical development
• In which therapeutic areas and phases of development mHealth technologies are used most often
• Anticipated changes in mHealth use over the next 2 years

How to use:

• Gather information on industry practices and usage patterns to make informed decisions about implementing mHealth technologies in clinical research
• Discover cost-saving opportunities facilitated by the use of mHealth technologies
• Learn about current operational realities and barriers to the implementation of mHealth

Major Topics:

• mHealth Market Dynamics
• mHealth Implementation
• How mHealth Impacts Costs
• mHealth Operational Realities
• Barriers to mHealth Utilization in Clinical Development